Erasme Scientific Publications

Erasme Scientific Publications

Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.

Fontana M, Berk JL, Gillmore JD, Witteles RM, Grogan M, Drachman B, Damy T, Garcia-Pavia P, Taubel J, Solomon SD, Sheikh FH, Tahara N, González-Costello J, Tsujita K, Morbach C, Pozsonyi Z, Petrie MC, Delgado D, Van der Meer P, Jabbour A, Bondue A, Kim D, Azevedo O, Hvitfeldt Poulsen S, Yilmaz A, Jankowska EA, Algalarrondo V, Slugg A, Garg PP, Boyle KL, Yureneva E, Silliman N, Yang L, Chen J, Eraly SA, Vest J, Maurer MS

Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.

Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.

Fontana M, Berk JL, Gillmore JD, Witteles RM, Grogan M, Drachman B, Damy T, Garcia-Pavia P, Taubel J, Solomon SD, Sheikh FH, Tahara N, González-Costello J, Tsujita K, Morbach C, Pozsonyi Z, Petrie MC, Delgado D, Van der Meer P, Jabbour A, Bondue A, Kim D, Azevedo O, Hvitfeldt Poulsen S, Yilmaz A, Jankowska EA, Algalarrondo V, Slugg A, Garg PP, Boyle KL, Yureneva E, Silliman N, Yang L, Chen J, Eraly SA, Vest J, Maurer MS

Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

Hoyois A, Gulkilik C, Mekkaoui L, Dahma H, Wambacq V, Minsart C, Rosewick N, Liefferinckx C, Amininejad L, Van Gossum A, Cremer A, Vandenberg O, Franchimont D

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

Hoyois A, Gulkilik C, Mekkaoui L, Dahma H, Wambacq V, Minsart C, Rosewick N, Liefferinckx C, Amininejad L, Van Gossum A, Cremer A, Vandenberg O, Franchimont D

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

Hoyois A, Gulkilik C, Mekkaoui L, Dahma H, Wambacq V, Minsart C, Rosewick N, Liefferinckx C, Amininejad L, Van Gossum A, Cremer A, Vandenberg O, Franchimont D

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

Hoyois A, Gulkilik C, Mekkaoui L, Dahma H, Wambacq V, Minsart C, Rosewick N, Liefferinckx C, Amininejad L, Van Gossum A, Cremer A, Vandenberg O, Franchimont D

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

Hoyois A, Gulkilik C, Mekkaoui L, Dahma H, Wambacq V, Minsart C, Rosewick N, Liefferinckx C, Amininejad L, Van Gossum A, Cremer A, Vandenberg O, Franchimont D

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

Hoyois A, Gulkilik C, Mekkaoui L, Dahma H, Wambacq V, Minsart C, Rosewick N, Liefferinckx C, Amininejad L, Van Gossum A, Cremer A, Vandenberg O, Franchimont D

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

Phenotyping patients treated for obstructive sleep apnea with persistent objective impaired alertness or subjective sleepiness.

Tankéré P, Taillard J, Stauffer E, Petitjean T, Berthomier C, Strauss M, Tamisier R, Peter-Derex L

Phenotyping patients treated for obstructive sleep apnea with persistent objective impaired alertness or subjective sleepiness.

Huderf hospital

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital

Scientific publications from the Queen Fabiola Children's Hospital

Bordet hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications

Scientific publications by Jules Bordet

Decorative image of doctor and patient

All scientific publications by the H.U.B.

View all scientific publications from the H.U.B.

All scientific publications